CHIESI GROUP

* More than 8,000 employees
* 31 subsidiaries worldwide
* 3 production sites (France, Italy, Brazil)
* 7 research centers (France, Italy, Suède, UK, USA, Canada, China)
More than 560 people and more than € 884 million invested in R & D in 2025
* € 3,600 million in revenue in 2025


CHIESI FRANCE

*More than 580 employees (271 people at headquarters and in the field, 261 people at the factory)

* € 237 million in revenue in 2025

Respiratory diseases are at the heart of the expertise of the CHIESI laboratory, accounting for nearly 90% of turnover including neonatology with the management of respiratory distress of the newborn.

The Innovair range represents a preponderant share of turnover.

Development of Chiesi increasingly important in Rare Diseases.

At the factory at Chaussée-Saint-Victor,

More than € 22 million in Euros has been invested in a new production line. Grouping 8200 m² of surface including 600 m² room under controlled atmosphere.

Nearly 40 million units will be produced in 2023 and more than 80% of the production will be exported.